| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996833 | Practical Radiation Oncology | 2015 | 6 Pages |
Abstract
Using the NCDB, we identified a concerning decline in the utilization of brachytherapy boost for those with vaginal cancer and a corresponding increase in IMRT boost technique. The strongest factor predicting for brachytherapy boost utilization is treatment at a high volume facility.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Malolan S. MD, Karen M. BS, Jeff MD, Karyn MD, Paniti MD, Thomas C. MD, Joseph L. MD, Sushil MD,